4.7 Article

Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Clinical Neurology

Pseudoprogression Following Chemoradiotherapy for Glioblastoma Multiforme

Paul Sanghera et al.

CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES (2010)

Article Oncology

Temozolomide Versus Procarbazine, Lomustine, and Vincristine in Recurrent High-Grade Glioma

Michael Brada et al.

JOURNAL OF CLINICAL ONCOLOGY (2010)

Review Oncology

New (alternative) temozolomide regimens for the treatment of glioma

Wolfgang Wick et al.

NEURO-ONCOLOGY (2009)

Article Oncology

Validation of the M.D. Anderson Symptom Inventory Brain Tumor Module (MDASI-BT)

T. S. Armstrong et al.

JOURNAL OF NEURO-ONCOLOGY (2006)

Article Oncology

Targeted modulation of MGMT: Clinical implications

LL Liu et al.

CLINICAL CANCER RESEARCH (2006)

Article Medicine, General & Internal

MGMT gene silencing and benefit from temozolomide in glioblastoma

ME Hegi et al.

NEW ENGLAND JOURNAL OF MEDICINE (2005)

Article Medicine, General & Internal

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

R Stupp et al.

NEW ENGLAND JOURNAL OF MEDICINE (2005)

Article Medicine, General & Internal

Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents

M Esteller et al.

NEW ENGLAND JOURNAL OF MEDICINE (2000)